Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Flaxseed and cardiovascular risk.
Bloedon LT, Szapary PO. Bloedon LT, et al. Nutr Rev. 2004 Jan;62(1):18-27. doi: 10.1111/j.1753-4887.2004.tb00002.x. Nutr Rev. 2004. PMID: 14995053 Review.
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Bloedon LT, et al. J Am Coll Nutr. 2008 Feb;27(1):65-74. doi: 10.1080/07315724.2008.10719676. J Am Coll Nutr. 2008. PMID: 18460483 Clinical Trial.
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.
Bloedon LT, Dunbar R, Duffy D, Pinell-Salles P, Norris R, DeGroot BJ, Movva R, Navab M, Fogelman AM, Rader DJ. Bloedon LT, et al. J Lipid Res. 2008 Jun;49(6):1344-52. doi: 10.1194/jlr.P800003-JLR200. Epub 2008 Mar 6. J Lipid Res. 2008. PMID: 18323573 Free PMC article.
Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models.
Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. Pellizzon MA, et al. J Am Coll Nutr. 2007 Feb;26(1):66-75. doi: 10.1080/07315724.2007.10719587. J Am Coll Nutr. 2007. PMID: 17353585
Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.
Samaha FF, Szapary PO, Iqbal N, Williams MM, Bloedon LT, Kochar A, Wolfe ML, Rader DJ. Samaha FF, et al. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30. doi: 10.1161/01.ATV.0000200136.56716.30. Epub 2005 Dec 15. Arterioscler Thromb Vasc Biol. 2006. PMID: 16357312 Clinical Trial.
Physical activity and its effects on lipids.
Szapary PO, Bloedon LT, Foster GD. Szapary PO, et al. Curr Cardiol Rep. 2003 Nov;5(6):488-92. doi: 10.1007/s11886-003-0112-2. Curr Cardiol Rep. 2003. PMID: 14558992 Review.
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.
Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ. Szapary PO, et al. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284192 Clinical Trial.
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Cuchel M, et al. N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189. N Engl J Med. 2007. PMID: 17215532 Clinical Trial.
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.
Samaha FF, McKenney J, Bloedon LT, Sasiela WJ, Rader DJ. Samaha FF, et al. Nat Clin Pract Cardiovasc Med. 2008 Aug;5(8):497-505. doi: 10.1038/ncpcardio1250. Epub 2008 May 27. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18506154 Clinical Trial.
Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial.
Cohen DL, Bloedon LT, Rothman RL, Farrar JT, Galantino ML, Volger S, Mayor C, Szapary PO, Townsend RR. Cohen DL, et al. Among authors: bloedon lt. Evid Based Complement Alternat Med. 2011;2011:546428. doi: 10.1093/ecam/nep130. Epub 2011 Feb 14. Evid Based Complement Alternat Med. 2011. PMID: 19734256 Free PMC article.
25 results
Jump to page
Feedback